Given that upregulation of Shp2 expression resulted in impaired inner retinal function in WT but the effects were less significant in Cav-1 ablated retinas; we examined whether Shp2 silencing could protect inner retinal function in glaucoma and tested this premise in two different models of experimental glaucoma. This evidence concerns the gene CAV1 and glaucoma.